Diurnal intraocular pressure and blood pressure with two dosing regimens of brimonidine in normal tension glaucoma

Catherine Jui Ling Liu, Ching Yu Cheng, Yu Chieh Ko, Wen-Ming Hsu

研究成果: 雜誌貢獻文章同行評審

11 引文 斯高帕斯(Scopus)

摘要

Background. To compare the effects of 2 dosing regimens of brimonidine tartrate 0.2% on diurnal intraocular pressure (IOP) and systemic hemodynamics in patients with normal-tension glaucoma (NTG). Methods. Twenty NTG patients were enrolled and randomized to receive either brimonidine twice daily (BID) for 4 weeks followed by brimonidine 3 times daily (TID) for another 4 weeks, or in reverse order. Diurnal variations of IOP and ocular perfusion pressure (OPP), as well as the 24-hour ambulatory blood pressure (BP) and pulse rate, were evaluated at baseline and after treatment. Baseline and post-treatment data were compared using a paired Student's t test, and treatment effects were compared between regimens using a crossover-designed analysis of variance. Results. Both regimens decreased the mean (p<0.001) and minimum (p<0.001) diurnal IOP, and only the TID regimen decreased the maximum IOP with a marginal significance (p = 0.049). The TID regimen decreased the maximum OPP (p = 0.009) while the BID regimen caused no changes in OPP. No significant difference in IOP or OPP was noted between regimens at each time point. Neither regimen caused changes in BP or pulse rate as assessed using the 24-hour ambulatory monitoring device. Conclusions. The TID regimen of brimonidine produces similar reductions in diurnal IOP for NTG patients as the BID regimen, and it alone decreases the maximum OPP. Neither of the 2 regimens causes exaggerated nocturnal reduction of BP.

原文英語
頁(從 - 到)465-471
頁數7
期刊Journal of the Chinese Medical Association
67
發行號9
出版狀態已發佈 - 九月 1 2004
對外發佈Yes

ASJC Scopus subject areas

  • Medicine(all)

指紋 深入研究「Diurnal intraocular pressure and blood pressure with two dosing regimens of brimonidine in normal tension glaucoma」主題。共同形成了獨特的指紋。

引用此